Xencor Inc (XNCR) stock
XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)
Close on Nov 18, 2026Market cap $2.56BP/E –Yield –
Xencor total assets
Total assets on the balance sheet at the end of each period.
Xencor's total assets was $724.96M at Jun 30, 2026. For fiscal 2025 it was $875.50M, down 8.0% from the year before. Over ten years it grew 15.5% a year on average. The highest annual figure on record is $965.14M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $875.50M | -8.0% |
| FY2024 | Dec 31, 2024 | $951.95M | -1.4% |
| FY2023 | Dec 31, 2023 | $965.14M | +14.0% |
| FY2022 | Dec 31, 2022 | $846.27M | +1.0% |
| FY2021 | Dec 31, 2021 | $838.21M | +19.2% |
| FY2020 | Dec 31, 2020 | $703.24M | +4.9% |
| FY2019 | Dec 31, 2019 | $670.25M | +16.2% |
| FY2018 | Dec 31, 2018 | $576.73M | +47.8% |
| FY2017 | Dec 31, 2017 | $390.20M | -9.0% |
| FY2016 | Dec 31, 2016 | $428.56M | +107.1% |
| FY2015 | Dec 31, 2015 | $206.91M | +205.1% |
| FY2014 | Dec 31, 2014 | $67.82M | -22.3% |
| FY2013 | Dec 31, 2013 | $87.32M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $724.96M | -17.6% |
| Q1 FY2026 | Mar 31, 2026 | $736.85M | -18.6% |
| Q4 FY2025 | Dec 31, 2025 | $875.50M | -8.0% |
| Q3 FY2025 | Sep 30, 2025 | $868.81M | -13.1% |
| Q2 FY2025 | Jun 30, 2025 | $879.42M | +4.6% |
| Q1 FY2025 | Mar 31, 2025 | $904.69M | +0.9% |
| Q4 FY2024 | Dec 31, 2024 | $951.95M | -1.4% |
| Q3 FY2024 | Sep 30, 2024 | $999.90M | +28.5% |
| Q2 FY2024 | Jun 30, 2024 | $840.62M | +8.0% |
| Q1 FY2024 | Mar 31, 2024 | $896.85M | +11.6% |
| Q4 FY2023 | Dec 31, 2023 | $965.14M | +14.0% |
| Q3 FY2023 | Sep 30, 2023 | $778.43M | -6.8% |
| Q2 FY2023 | Jun 30, 2023 | $778.12M | -8.6% |
| Q1 FY2023 | Mar 31, 2023 | $803.41M | -6.4% |
| Q4 FY2022 | Dec 31, 2022 | $846.27M | +1.0% |
| Q3 FY2022 | Sep 30, 2022 | $835.27M | +19.8% |
| Q2 FY2022 | Jun 30, 2022 | $851.33M | +22.4% |
| Q1 FY2022 | Mar 31, 2022 | $857.92M | +23.8% |
| Q4 FY2021 | Dec 31, 2021 | $838.21M | +19.2% |
| Q3 FY2021 | Sep 30, 2021 | $697.26M | +7.9% |
| Q2 FY2021 | Jun 30, 2021 | $695.60M | +7.9% |
| Q1 FY2021 | Mar 31, 2021 | $692.74M | +3.9% |
| Q4 FY2020 | Dec 31, 2020 | $703.24M | +4.9% |
| Q3 FY2020 | Sep 30, 2020 | $646.35M | -5.8% |
| Q2 FY2020 | Jun 30, 2020 | $644.72M | -5.8% |
| Q1 FY2020 | Mar 31, 2020 | $666.96M | -4.3% |
| Q4 FY2019 | Dec 31, 2019 | $670.25M | +16.2% |
| Q3 FY2019 | Sep 30, 2019 | $686.24M | +17.2% |
| Q2 FY2019 | Jun 30, 2019 | $684.75M | +15.8% |
| Q1 FY2019 | Mar 31, 2019 | $697.00M | +13.8% |
| Q4 FY2018 | Dec 31, 2018 | $576.73M | +47.8% |
| Q3 FY2018 | Sep 30, 2018 | $585.59M | +47.0% |
| Q2 FY2018 | Jun 30, 2018 | $591.46M | +42.1% |
| Q1 FY2018 | Mar 31, 2018 | $612.27M | +46.4% |
| Q4 FY2017 | Dec 31, 2017 | $390.20M | -9.0% |
| Q3 FY2017 | Sep 30, 2017 | $398.26M | +23.6% |
| Q2 FY2017 | Jun 30, 2017 | $416.16M | – |
| Q1 FY2017 | Mar 31, 2017 | $418.30M | – |
| Q4 FY2016 | Dec 31, 2016 | $428.56M | – |
| Q3 FY2016 | Sep 30, 2016 | $322.13M | – |
See a number that looks wrong?